Clinical Trial Update: Escitalopram in Patients With Generalized Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update showing results for escitalopram in adults with Generalized Anxiety Disorder; the study has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2011-06-10